--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
NVIDIA
NVDA
Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
MTNB Matinas BioPharma
- 0.5201
- -0.0249-4.57%
Close Dec 23 16:00 ET
- 0.5201
- 0.00000.00%
Post 20:01 ET
2.65MMarket Cap-0.11P/E (TTM)
0.5588High0.5200Low76.25KVolume0.5500Open0.5450Pre Close40.46KTurnover1.54%Turnover RatioLossP/E (Static)5.09MShares21.500052wk High0.17P/B2.58MFloat Cap0.500052wk Low--Dividend TTM4.96MShs Float197.5000Historical High--Div YieldTTM7.12%Amplitude0.5000Historical Low0.5300Avg Price1Lot Size
Matinas BioPharma Key Stats
Matinas BioPharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Matinas BioPharma Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data